Developing tools to detect and treat CMV infections
Molecular Devices for the Detection and Treatment of HCMV Infection
This study is working on a new, easy-to-use device that helps post-transplant patients check for cytomegalovirus (CMV) infections at home using their smartphone, making it simpler to manage their health and reduce complications.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Upstate Medical University NIH-funded |
| Lab location | 1 site (Syracuse, United States) |
| Project ID | NIH-10916264 on NIH RePORTER |
What this research studies
This research focuses on creating innovative molecular devices to detect and manage cytomegalovirus (CMV) infections, particularly in post-transplant patients. It aims to develop a user-friendly detection platform that allows patients to self-screen for active CMV infections using a simple biosensor that can be read with a cell phone camera. The approach combines advanced techniques in protein and DNA engineering to enhance the sensitivity of detection and potentially improve treatment outcomes. By enabling at-home screening, the research seeks to reduce the burden of CMV-related complications in vulnerable patient populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include post-transplant patients who are at risk of CMV reactivation and require regular monitoring.
Not a fit: Patients who are not undergoing transplantation or who do not have a history of CMV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce CMV-related mortality in post-transplant patients by providing a more accessible and effective means of detection and treatment.
How similar studies have performed: Other research has shown promise in developing biosensors for viral detection, indicating that this approach could lead to successful outcomes.
Where this research is happening
Syracuse, United States
- Upstate Medical University — Syracuse, United States (Active)
Researchers
- Principal investigator: Sekhon, Harsimranjit S — Upstate Medical University
- Study coordinator: Sekhon, Harsimranjit S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.